Gamma Globin Gene “Switch On” by Dietary Source of Short Chain Fatty Acids as a Therapy for the Management of Sickle Cell Anaemia in Patients Attending Federal Medical Centre Gusau, Zamfara State
DOI:
https://doi.org/10.47430/ujmr.1611.018Keywords:
Sickle Cell Anaemia, Foetal Haemoglobin, Short Chain Fatty Acids, Nutritional Therapy, Gamma Globin chainAbstract
The effect of feeding Cow’s Milk butter as a nutritional source of short chain fatty acids on the level of foetal haemoglobin (Hb F) in patients with Sickle Cell Disease (SCD) was studied. A significant increase (P<0.05) was observed in the level of Hb F (1.0% to 2.5%) in all the patients treated with Cow’s Milk butter for a period of 6 months (180 days). An increase in the level of Hb F in the patients is an indication of molecular “switch on” of the gamma globin gene responsible for the production of gamma globin chain found in Hb F. Increase in production of Hb F can serve as a therapy for the management of sickle cell anaemia (SCA).
Downloads
References
Alex, S.(2015). Sickle Cell Disease Nigeria has the largest cases in the world- Research, www.vanguardngr.com,20 june 2015.
Attah, E.B.and Ekere, M.C.(1975). Death pattern in Sickle Cell Anaemia. JAMA 233:889-890.
https://doi.org/10.1001/jama.233.8.889
Brewer, G. J., Brewer, L. F. and Prasad, A.S. (1977). Suppression of irreversiblu sickled erythrocytes by zinc therapy in sickle cell anaemia. Journal of Laboratory and clinical medicine. 90:549 - 554.
Brewer, G. J. And Bereza, U. (1982). Membrane therapy of sickle cell anaemia with zinc and other drugs. In Fried W. Edn. Comparative clinical aspect of sickle cell disease. Amsterdam El-servier, North Holland. 175-187.
Betke, K., Martin, H.R and Schlicht, J. (1959).Estimation of small percentage of Foetal Haemoglobin. Nature, 184 : 1877.
https://doi.org/10.1038/1841877a0
Bunn, H.F (1997). Mechanism of Diesease: Pathogenesis and treatment of Sickle Cell Disease. N. Engl J. Med. 337(11) : 762 - 769.
https://doi.org/10.1056/NEJM199709113371107
Charache, S., Dover, G.J Moyer M.A. and Moore J.W. (1987). Hydroxyurea induced argumentation of fetal haemoglobin production in patients with sickle cell anaemia. Blood 69: 109 - 116.
https://doi.org/10.1182/blood.V69.1.109.109
Constantoulakis, P., Knitter, G., and Stamatoyannopoulos, G. (1989). On the induction of fetal haemoglobin by butyrates : in Vivo and in vitro studies with sodium butyrate and comparison of combination treatment with 5 - a zac and arac. Blood 74 : 1963 - 1971.
https://doi.org/10.1182/blood.V74.6.1963.bloodjournal7461963
Dacie, J.V and Lewis, S.M (1984). Practical haematology. Churchill Livingstone, New York 6th edu., 237 - 238
Desimone, J., Heller, P., Hall L. and Zwiers,D. (1982). 5 - Azacytidine stimulates fetal haemoglobin synthesis in anemic baboons. Proceedings of National Academy of Science, USA 79: 4428 - 4431.
https://doi.org/10.1073/pnas.79.14.4428
Herrick K, J.B (1910). Peculiar elongated and sickle shaped red blood corpuscles in a case of severe anaemia. Archives of Internal Medicine 6 : 517 - 521.
https://doi.org/10.1001/archinte.1910.00050330050003
Huntsman, R.G. and Lehmann, H. (1974). Treatment of Sickle Cell Disease. Brit. J. Haemat. 28:437 - 444.
https://doi.org/10.1111/j.1365-2141.1974.tb06662.x
Jain, R.C and Dar, F.K. (1981). Sickle Cell Trait, thalassemia and Glucse -6- phosphate dehydrogenase deficiency in the Hospital population of Benghazi Garyounis Med. J. 4(10) : 35 - 38.
Ley, T.J., Desimone, J. and Anagnou, N.P (1982). 5 - Azacytidine Selectively increase gamma - globin synthesis in a patient with beta (+) thalassemia. New England Journal of Medicine 307 : 1469 - 1475.
https://doi.org/10.1056/NEJM198212093072401
Matazu K. I., Bilbis, L. S. and Shehu, R. A.(2004). Detection of some antisickling agents in some commonly consumed foodstuff. Nig.J. Biochem. Mol.Bio. 19(1):37-40. Miller, A. A., Kurschel, E., Osiela, R and
Schmidt, C.G (1987). Clinical pharmacology of sodium Butyrate in patients with acute levkemia. Eur. J. cancer clin. Oncol 23 1283- 1287.
https://doi.org/10.1016/0277-5379(87)90109-X
Neel, J.V. (1949). The inheritence of Sickle Cell Anaemia. Science. 110 :64 - 66
https://doi.org/10.1126/science.110.2846.64
Pauling, L. Itano, H. A., Singer, S. J. and Well, I. C. (1949). Sickle Cell Anaemia:A molecular disease. Science 110:543-548.
https://doi.org/10.1126/science.110.2865.543
Pearson, H. A. (1983). Therapy of Sickle cell disease. Abstract of the 8th Saudi Medical meeting, Riyadh, Saudi Arabia. 145 - 146.
Pembrey, M.E, Wood, W.G, Weatheral, D.J and Perrine, R.P (1978). Fetal hemoglobin production and the sickle gene in the cases of Eastern Saudi Arabia. British Journal of Haematology. 40:415 - 429.
https://doi.org/10.1111/j.1365-2141.1978.tb05813.x
Perrine, S.P., Rudolph, A., Faller, V.D.,Roman, C., Cohen, R.A., Chen, J.S and Kan,Y.W. (1988).Butyrate infusions in the ovine fetus delay the biological clock for the globin gene switching. Proc. Natl. Acad. Sci. USA: 85: 8540 - 8542.
https://doi.org/10.1073/pnas.85.22.8540
Perrine, S.P., Ginder, G.D., Faller, D.V., Dover, G.H., Ikuta, T., Witkowska H.E., Cai,S.P., Vichinsky, E.P and Olivievi, N.F (1993). A short term trial of butyrate to stimulate fetal globin gene expression in the Beta - globin disorders. N.Engl. J Med. 328(2) 81 - 86.
https://doi.org/10.1056/NEJM199301143280202
Platt, O.S., Orkin, S.H Dover, G., Beardstey, G.P., Miller, B. and Nathan, D.G. (1984). Hydroxyurea enhances fetal haemoglobin production in sickle cell Anaemia. Journal of Clinical Medicine. 74: 654 - 656.
https://doi.org/10.1172/JCI111464
Platt, O. S., Thorington B. D., Brambilla, D. J., Miller, P. F. Rose, W. F., Vinchnsky, E. And Kinney T. R.(1991). Pain in sickle cell disease, rates and risk factors. New England Journal of Medicine. 325: 11-16
https://doi.org/10.1056/NEJM199107043250103
Rodgers, G. P., Dover, G.J., Noguchi, C. T., Shechter, A. N. And Nienhuis, A. W.(1990). Haematological response of patients with Sickle Cell Disease to treatment with hydroxyurea. New England Journal of Medicine, 322:1037-1045.
https://doi.org/10.1056/NEJM199004123221504
Sher, G.D., Ginder, C.D., Little, J., Yang, S., Dover, G.J and Olivievi, N.F (1995). Extended therapy with Intra-Venous arginine butyrate in patients with Beta- haemoglobinopathies. New England Journal of Medicine. 332 (24) : 1606 - 1610.
https://doi.org/10.1056/NEJM199506153322404
Vanderploeg, L.H.T and Flavell, R.A. (1989). DNA methylation in the human gamma, delta and beta globin locus in erythroid and non evrthroid Tissue. Cell 19: 947 - 958.
https://doi.org/10.1016/0092-8674(80)90086-0
Warsy, A.S., El -Hazmi, M.A.F. and Bahakim, H.M (1985). Molecular therapy of Sickle cell anaemia : The state of the art. Saudi Medical Journal. 6(3):257 - 263.
White, A., Handler P., Smith, E. L., Hill, R. And Lehmann, I. R.(1978). Principles of Biochemistry. 6th edn. McGraw-Hill Kaga Kusha ltd. Tokyo, 947-983.
World Health Organization (WHO), (1972). Treatment of haemoglobinopathies and allied disorder. Technical report. No 509, Geneva, 3 - 9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
